about
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor RadiosensitizationAccelerated Partial Breast Irradiation in Clinical PracticeEndothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors.Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.Establishment of a Radiogenomics Consortium.Relative Biologic Effectiveness (RBE) of 50 kV X-rays measured in a phantom for intraoperative tumor-bed irradiation.INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation studyCan the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivoEpigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis.Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation.The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.Biology of high single doses of IORT: RBE, 5 R's, and other biological aspectsRadioprotection of normal tissue cells.Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines.The influence of retinoic Acid and thalidomide on the radiosensitivity of u343 glioblastoma cells.Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line.Smart Radiation Therapy Biomaterials.Overexpression of manganese superoxide dismutase does not increase clonogenic cell survival despite effect on apoptosis in irradiated lymphoblastoid cells.MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT).SNAI2 as a novel radioprotector of normal tissue by gene transfer using a lentiviral bicistronic SIN vector.Overexpression of caveolin-1 in lymphoblastoid TK6 cells enhances proliferation after irradiation with clinically relevant doses.Normal-tissue radioprotection by overexpression of the copper-zinc and manganese superoxide dismutase genes.Inhibition of 13-cis retinoic acid-induced gene expression of homeobox B7 by thalidomide.Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy.Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistanceCorrelation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy.Growth-state-dependent radiation-induced expression of the proto-oncogene c-fos in NIH 3T3 cells.Recombinant adeno-associated virus 2-mediated transfer of the human superoxide-dismutase gene does not confer radioresistance on HeLa cervical carcinoma cells.Irradiated homozygous TGF-beta1 knockout fibroblasts show enhanced clonogenic survival as compared with TGF-beta1 wild-type fibroblasts.Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.P03.05THE HIV-DERIVED PROTEIN VPR(52-96) HAS PRO-APOPTOTIC AND ANTIPROLIFERATIVE ACTIVITY IN GLIOBLASTOMA CELL LINES IN VITRO.Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.
P50
Q26771165-3B90666A-19A8-4C4F-8CE6-D7B572C199B2Q26776283-398072DF-343E-4FEE-9686-3A023A576268Q30652492-A5D5E578-95DC-4D37-88D9-5C13601F40EDQ33252768-52DDC8F4-9BC5-44F4-BD35-C6BA144CD5B6Q33354322-037EBD2A-5084-4B74-8478-15A8E8C57EBEQ34106703-A83EDE48-E4FF-450B-BCEB-CE799A0E5CD4Q34415285-A92D1AF1-3C5E-4E73-9BF7-935BF61BC2CEQ35189570-53B071D5-BB81-495A-B90B-CD8F11A1F62CQ35677383-190956E9-9918-42ED-84E6-9A11706FB8D1Q36121570-EF2E58C4-610D-4A9A-B03C-9C50DFB6B20FQ36557180-B8AD5B98-2DFF-42A9-B2FE-F03E1FE21BC5Q36690194-4BA12EFC-B96D-4D21-ABDA-9DE0EC5DC556Q37235167-CCDB84C8-587F-42A3-B781-26C2D9A9D7F2Q37504688-92FD5178-A361-468C-8D94-283F13EFC4D3Q37564463-B29FC5E3-CBE4-4720-B496-2AEE0A208436Q37597275-C9FA402A-920C-4A65-AA56-DB37B4BC043DQ38196712-32498E01-560B-443D-B935-CD0C13FABDB8Q38632924-82460E8C-57C8-4BA6-B8A9-1BA221DFEC4DQ38761174-E8040216-4B33-4C0F-B338-59FFBA1CBB62Q38900782-04A36770-B95E-4762-9167-D52E652BC78AQ39009028-322E59E9-7E14-4C39-B768-FBD80FBC6428Q39097617-4B549ED7-92F2-42B8-9CDB-7ACB80416D7FQ39105322-77E5F18C-6BE2-4BBF-AE21-67B3CF6EC258Q39478087-CB6E452D-42C1-448D-8A74-8A4061F61DFCQ39619832-A65999C8-FC4A-4CCD-8AB7-A0373EC0DE38Q39630443-68C3AE84-6115-4FA7-A2A8-F9ABD3DC69EDQ39709910-BC86134C-7241-40F8-B527-1FC7B5B0B1EBQ39744649-89F69359-4DCF-4487-95D4-277B01E2A6E9Q39817137-9B400360-DCEF-49A9-9D76-446BA7D4DA72Q40130165-616D024D-B0D0-41B4-9038-6C1D91BA92CDQ40183112-1A2DEA24-3B03-4BEE-BF63-8A2205DA344AQ42121834-31B63E0D-826E-492E-AA35-1CFDD68173CCQ42492246-9082E57D-D91D-450B-82BC-F07645FE9E61Q42815580-012A67F4-5B47-4C56-B0D9-BA430AF2FCEBQ43418021-2844C024-7889-405B-BF6A-8D9F03154C24Q43999987-F364A0CE-BF75-4E9C-84D6-7EADBEF66D4EQ46579046-B3C5A430-0C78-4607-914A-CF2C98F2D8B9Q46843010-D762A08C-39F0-4837-AECA-E58740FF426CQ46880846-5AE3DB88-502A-4BC0-9DEF-E88B8CBD7850Q46886245-7831EB24-CC3B-4414-8C32-44E07EAF6F1C
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Carsten Herskind
@ast
Carsten Herskind
@en
Carsten Herskind
@es
Carsten Herskind
@nl
Carsten Herskind
@sl
type
label
Carsten Herskind
@ast
Carsten Herskind
@en
Carsten Herskind
@es
Carsten Herskind
@nl
Carsten Herskind
@sl
prefLabel
Carsten Herskind
@ast
Carsten Herskind
@en
Carsten Herskind
@es
Carsten Herskind
@nl
Carsten Herskind
@sl
P214
P106
P21
P214
P2798
P31
P496
0000-0001-6554-5907
P734
P735
P7859
viaf-287991972